Needham Initiates Coverage On Immunocore Hldgs with Buy Rating, Announces Price Target of $75
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Gil Blum has initiated coverage on Immunocore Holdings (NASDAQ:IMCR) with a Buy rating and a price target of $75.
September 13, 2023 | 10:22 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Immunocore Holdings (NASDAQ:IMCR) has been initiated with a Buy rating by Needham, with a price target of $75.
The initiation of coverage by Needham with a Buy rating and a high price target indicates a positive outlook for Immunocore Holdings. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100